# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-011769
Filing Date
2022-03-30
Accepted
2022-03-30 11:02:14
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20001934x2_defa14a.htm | DEFA14A | 18547
2 |  | ny20001934x2_nc01.jpg | GRAPHIC | 717341
3 |  | ny20001934x2_nc02.jpg | GRAPHIC | 440383
| Complete submission text file | 0001140361-22-011769.txt |  | 1575482

Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 0101
Type: DEFA14A | Act: 34 | File No.: 001-35024 | Film No.: 22783889
SIC: 2833 Medicinal Chemicals & Botanical Products